Joaquín Sánchez‐García

Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry

Teresa Bernal, Pablo Martínez‐Camblor, Joaquín Sánchez‐García et al. · Leukemia · 2015 · 104 citations · Full text

Hematological Malignancy, Spanish Registry, Hematology +5

A novel 33‐Gene targeted resequencing panel provides accurate, clinical‐grade diagnosis and improves patient management for rare inherited anaemias

Noémi Roy, Edward A. Wilson, Shirley Henderson et al. · British Journal of Haematology · 2016 · 88 citations · Full text

Immunohematology, Genetic Testing, Genetics +27

Aberrant Bcl6 Protein Expression in Mantle Cell Lymphoma

Francisca I. Camacho, Juan F. Garcı́a, Juan C. Cigudosa et al. · The American Journal of Surgical Pathology · 2004 · 58 citations

Hematological Malignancy, Lymphoid Neoplasia, Mantle Cell Lymphoma +13

Quantification of minimal residual disease levels by flow cytometry at time of transplant predicts outcome after myeloablative allogeneic transplantation in ALL

Joaquín Sánchez‐García, Josefina Serrano, Juana Serrano‐López et al. · Bone Marrow Transplantation · 2012 · 35 citations

Transplant Predicts, Flow Cytometry, Transplantation +9

Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid Leukemia

Isabel Valhondo, Fakhri Hassouneh, Nelson López-Sejas et al. · Cancers · 2020 · 33 citations · Full text